Gene · 4157
Papers3,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human cutaneous interfollicular melanocytes differentiate temporarily under genotoxic stress. | iScience | 2022 | 36274944 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma. | Int J Mol Sci | 2022 | 36233269 | PubTator, text mining | PubMed |
| Familial Linkage and Association of the NR3C1 Gene with Type 2 Diabetes and Depression Comorbidity. | Int J Mol Sci | 2022 | 36233250 | PubTator, text mining | PubMed |
| Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review. | Int J Environ Res Public Health | 2022 | 36231404 | PubTator, text mining | PubMed |
| Melanoma Management: From Epidemiology to Treatment and Latest Advances. | Cancers (Basel) | 2022 | 36230575 | PubTator, text mining | PubMed |
| Characterization of the Sarcidano Horse Coat Color Genes. | Animals (Basel) | 2022 | 36230420 | PubTator, text mining | PubMed |
| Basal Reactivity Evaluated by Infrared Thermography in the "Caballo de Deporte Español" Horse Breed According to Its Coat Color. | Animals (Basel) | 2022 | 36230256 | PubTator, text mining | PubMed |
| 'I had a bigger cancer risk than I thought…': The experience of receiving personalized risk information as part of a skin cancer prevention intervention in the college setting. | Health Expect | 2022 | 36225123 | PubTator, text mining | PubMed |
| Current understanding of epigenetics role in melanoma treatment and resistance. | Cancer Cell Int | 2022 | 36224606 | PubTator, text mining | PubMed |
| Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies. | BMC Med | 2022 | 36199081 | PubTator, text mining | PubMed |
| Accelerating skin regeneration and wound healing by controlled ROS from photodynamic treatment. | Inflamm Regen | 2022 | 36192814 | PubTator, text mining | PubMed |
| Acute corneal melt and perforation - A possible complication after riboflavin/UV-A crosslinking (CXL) in keratoconus. | Am J Ophthalmol Case Rep | 2022 | 36187442 | PubTator, text mining | PubMed |
| Congenital lipoid adrenal hyperplasia with Graves' disease: A case report. | World J Clin Cases | 2022 | 36159444 | PubTator, text mining | PubMed |
| UVA Radiation, DNA Damage, and Melanoma. | ACS Omega | 2022 | 36157735 | PubTator, text mining | PubMed |
| Microarray analysis reveals the potential molecular mechanism of Lp299v in stable coronary atherosclerotic disease. | AMB Express | 2022 | 36152115 | PubTator, text mining | PubMed |
| Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin αvβ3 for Pancreatic Cancer Imaging. | Pharmaceutics | 2022 | 36145541 | PubTator, text mining | PubMed |
| Dosimetry of [212Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free 208Tl on Tissue Absorbed Doses. | Molecules | 2022 | 36144563 | PubTator, text mining | PubMed |
| Pig Coat Color Manipulation by MC1R Gene Editing. | Int J Mol Sci | 2022 | 36142269 | PubTator, text mining | PubMed |
| New Approach to Addison Disease: Oral Manifestations Due to Endocrine Dysfunction and Comorbidity Burden. | Diagnostics (Basel) | 2022 | 36140482 | PubTator, text mining | PubMed |
| Intra-Abdominal Malignant Melanoma: Challenging Aspects of Epidemiology, Clinical and Paraclinical Diagnosis and Optimal Treatment-A Literature Review. | Diagnostics (Basel) | 2022 | 36140455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4157/papers?page=29